Literature DB >> 2690101

The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.

B Reisberg1, S H Ferris, M J de Leon, A Kluger, E Franssen, J Borenstein, R C Alba.   

Abstract

A series of studies published over the past 6 years now permit a relatively precise description of the temporal course of Alzheimer's disease (AD). Initially, 7 global stages of CNS aging and AD were described. Subsequently, data on the stage specific relationship between these stages and widely employed mental status, psychometric, and other assessment measures were collected. Longitudinal studies helped to clarify the borders between normal CNS aging and AD using these measures. Other studies described functioning and self-care correlates of the 7 global stages. These were ultimately divisible into 16 clearly defined, ordinal functional stages. Empirical longitudinal observations permitted the description of the mean temporal course of each of the 16 functional stages of aging and AD. The cross-sectional stage specific data on mental status and other measures can now be applied to the mean temporal course observations and the validity of the temporal estimates forwarded can be investigated in detail. Etiologic hypotheses based upon the observed phenomenologic and temporal course of AD are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2690101

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  15 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

Review 2.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

3.  Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.

Authors:  Tzeyu L Michaud; Robin High; Mary E Charlton; Daniel L Murman
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

4.  Relationship satisfaction and emotional language in frontotemporal dementia and Alzheimer disease patients and spousal caregivers.

Authors:  Elizabeth A Ascher; Virginia E Sturm; Benjamin H Seider; Sarah R Holley; Bruce L Miller; Robert W Levenson
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

Review 5.  Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Authors:  L Parnetti; U Senin; P Mecocci
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 7.  Is it really Alzheimer's?

Authors:  M A Spooner
Journal:  Can Fam Physician       Date:  1994-06       Impact factor: 3.275

8.  Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.

Authors:  Carina Wattmo; Asa K Wallin; Lennart Minthon
Journal:  BMC Neurol       Date:  2012-11-05       Impact factor: 2.474

9.  A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.

Authors:  Carina Wattmo; Elisabeth Paulsson; Lennart Minthon; Elisabet Londos
Journal:  Clin Interv Aging       Date:  2013-03-20       Impact factor: 4.458

10.  Detection of delirium by nurses among long-term care residents with dementia.

Authors:  Philippe Voyer; Sylvie Richard; Lise Doucet; Christine Danjou; Pierre-Hugues Carmichael
Journal:  BMC Nurs       Date:  2008-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.